Bangkok Genomics Innovation PCL (BKK:BKGI)

Thailand flag Thailand · Delayed Price · Currency is THB
1.290
+0.020 (1.57%)
Feb 10, 2026, 4:36 PM ICT
Market Cap774.00M -44.9%
Revenue (ttm)333.02M +12.4%
Net Income31.65M -28.9%
EPS0.05 -37.5%
Shares Out600.00M
PE Ratio24.45
Forward PE28.67
Dividend0.05 (3.94%)
Ex-Dividend Daten/a
Volume546,900
Average Volume195,169
Open1.270
Previous Close1.270
Day's Range1.260 - 1.310
52-Week Range1.110 - 2.400
Betan/a
RSI55.04
Earnings DateFeb 26, 2026

About BKK:BKGI

Bangkok Genomics Innovation Public Company Limited provides medical analysis services in Thailand. The company offers screening for fetal chromosomal abnormalities using non-invasive prenatal testing under the NIFTY brand; preimplantation chromosomal abnormality and thalassemia carrier gene screening; infectious disease group analysis; testing for human papilloma virus; and monkeypox virus, COVID-19 Pathogen, and COVID-19 pathogen immunity testing. It also provides other screening tests, such as cancer-related gene screening to predict the risk... [Read more]

Sector Healthcare
Founded 2017
Country Thailand
Stock Exchange Stock Exchange of Thailand
Ticker Symbol BKGI
Full Company Profile

Financial Performance

In 2024, BKK:BKGI's revenue was 337.59 million, an increase of 37.57% compared to the previous year's 245.39 million. Earnings were 50.17 million, an increase of 56.09%.

Financial Statements